Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial

Published:2017-07-17 Issue:11 Volume:44 Page:1228-1237
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Abe Masatoshi¹^ORCID,Nishigori Chikako²^ORCID,Torii Hideshi³,Ihn Hironobu⁴,Ito Kei⁵,Nagaoka Makoto⁶,Isogawa Naoki⁶,Kawaguchi Isao⁶,Tomochika Yukiko⁶,Kobayashi Mihoko⁶,Tallman Anna M.⁷,Papp Kim A.⁸

Affiliation:

1. Sapporo Skin Clinic; Sapporo Japan

2. Division of Dermatology; Kobe University; Kobe Japan

3. Division of Dermatology; Tokyo Yamate Medical Center; Tokyo Japan

4. Kumamoto University; Kumamoto Japan

5. JR Sapporo Hospital; Sapporo Japan

6. Pfizer Japan Inc; Tokyo Japan

7. Pfizer Inc; New York USA

8. Probity Medical Research and K. Papp Clinical Research Inc.; Waterloo Ontario Canada

Funder

Pfizer

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13956/fullpdf

Reference52 articles.

1. Psoriasis;Boehncke;Lancet,2015

2. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database;Mehta;Eur Heart J,2010

3. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis;Solomon;Ann Rheum Dis,2010

4. Psoriasis and diabetes: a population-based cross-sectional study;Cohen;J Eur Acad Dermatol Venereol,2008

5. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis;Shapiro;J Am Acad Dermatol,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upadacitinib in nail psoriasis: a case report;Journal of Dermatological Treatment;2023-09-04

2. Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis;Frontiers in Pharmacology;2023-08-08

3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

4. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

5. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens;Frontiers in Bioengineering and Biotechnology;2023-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3